Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Dailly

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Critical Care (London, England)|March 31, 2019
Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR)Romain Guilhaumou, Sihem Benaboud, Youssef Bennis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement projectCecile Lagarde, Marwan Bouras, Ronan Le Floch, et al.
JAMA|February 23, 2021
Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation: A Randomized Clinical TrialMickael Vourc'h, Charlotte Garret, Arnaud Gacouin, et al.
Open Forum Infectious Diseases|November 9, 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled TrialBenjamin Gaborit, Bernard Vanhove, Karine Lacombe, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort studyPaul Le Turnier, Dominique Navas, Denis Garot, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on NomogramMatthieu Grégoire, Eric Dailly, Paul Le Turnier, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa StudyBenjamin Gaborit, Eric Dailly, Bernard Vanhove, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Critical Care (London, England)|March 31, 2019
Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR)Romain Guilhaumou, Sihem Benaboud, Youssef Bennis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsClotilde Allavena, Virginie Ferré, Cécile Brunet-François, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement projectCecile Lagarde, Marwan Bouras, Ronan Le Floch, et al.
JAMA|February 23, 2021
Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation: A Randomized Clinical TrialMickael Vourc'h, Charlotte Garret, Arnaud Gacouin, et al.
Open Forum Infectious Diseases|November 9, 2023
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled TrialBenjamin Gaborit, Bernard Vanhove, Karine Lacombe, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2019
Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort studyPaul Le Turnier, Dominique Navas, Denis Garot, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on NomogramMatthieu Grégoire, Eric Dailly, Paul Le Turnier, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2021
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa StudyBenjamin Gaborit, Eric Dailly, Bernard Vanhove, et al.
Pageof 6